✦ LIBER ✦

Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union

✍ Scribed by Rehm, J.; Shield, K.D.; Gmel, G.; Rehm, M.X.; Frick, U.

Book ID: 122220844
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 498 KB
Volume: 23
Category: Article
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2012.08.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comorbid Alcohol and Substance Abuse Dep

Comorbid Alcohol and Substance Abuse Dependence in Depression: Impact on the Outcome of Antidepressant Treatment

✍ Ostacher, Michael J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Effect of early and late compliance on t

Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence

✍ Maarten W.J. Koeter; Wim van den Brink; Philippe Lehert 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Ethnic differences in the effect of drug

Ethnic differences in the effect of drug use and drug dependence on brief motivational interventions targeting alcohol use

✍ Craig A. Field; Gerald Cochran; Raul Caetano 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Modelling the impact of ivermectin on Ri

Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections

✍ Turner, Hugo C; Walker, Martin; Churcher, Thomas S; Basáñez, María-Gloria 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 734 KB

The effects of capping the alcohol consu

The effects of capping the alcohol consumption distribution and relative risk functions on the estimated number of deaths attributable to alcohol consumption in the European Union in 2004

✍ Gerrit Gmel, Kevin D Shield, Tara AK Kehoe-Chan… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 232 KB

A Mathematical Model of the Impact of No

A Mathematical Model of the Impact of Novel Treatments on the AβBurden in the Alzheimer’s Brain, CSF and Plasma

✍ David L Craft; Lawrence M Wein; Dennis J Selkoe 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 480 KB

With the advent of novel therapies for Alzheimer's disease, there is pressing need for biomarkers that are easy to monitor, such as the amyloid-beta (A beta) levels in the cerebrospinal fluid (CSF) and plasma. To gain a better understanding of the explanatory power of these biomarkers, we formulate